(Q44624552)

4 December 2017

title

Glucose metabolic dysfunction in subjects with a clinical dementia rating of 0.5. (English)

1 reference

4 December 2017

0 references

Kazunari Ishii

1

1 reference

4 December 2017

Tetsuya Mori

series ordinal

2

1 reference

4 December 2017

Nobutsugu Hirono

series ordinal

3

1 reference

4 December 2017

Etsuro Mori

series ordinal

4

1 reference

4 December 2017

publication date

1 November 2003

1 reference

Journal of the Neurological Sciences

4 December 2017

published in

1 reference

4 December 2017

volume

215

1 reference

4 December 2017

issue

1-2

1 reference

4 December 2017

page(s)

71-74

1 reference

Current concepts in mild cognitive impairment

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900206-5

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900206-5

The Clinical Dementia Rating (CDR): current version and scoring rules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900206-5

A New Systematic Method of Measurement and Diagnosis of “Mild Cognitive Impairment” and Dementia According to ICD-10 and DSM-III-R Criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900206-5

Mild cognitive impairment represents early-stage Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900206-5

Mild cognitive impairment or questionable dementia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900206-5

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900206-5

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900206-5

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900206-5

Presenilin-1-associated abnormalities in regional cerebral perfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900206-5

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900206-5

Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900206-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(03)00206-5

1 reference

4 December 2017

1 reference